Treatment response to nucleos(t)ide analogs in chronic hepatitis B with mildly elevated alanine aminotransferase: Letter to the editor on “Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial”

Documenti analoghi

• Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial
  di: Yao-Chun Hsu, et al.
  Pubblicazione: (2025-01-01)
• Tenofovir Disoproxil Fumarate and Entecavir in Patients with Chronic Hepatitis B: Efficacy and Safety Comparison
  di: Deniz Borcak, et al.
  Pubblicazione: (2026-04-01)
• Treatment response to nucleos(t)ide analogs in chronic hepatitis B with mildly elevated alanine aminotransferase: Letter to the editor on “Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial”
  di: Jian Wang, et al.
  Pubblicazione: (2025-04-01)
• Antiviral Efficacy and Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate in the Treatment of Chronic Hepatitis B
  di: Tuvshinbayar Narangerel, et al.
  Pubblicazione: (2020-12-01)
• Rapid suppression of HBV replication before related liver transplantation in a patient with HDV superinfection. Clinical case report
  di: U. R. Salimov, et al.
  Pubblicazione: (2024-09-01)